SCHEMBL31544971

SCHEMBL31544971

COOc1cccc(O)c1CCCCCCC(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 7/20 0.37
▸ CNR2 P34972 7/20 0.37
▸ NFKB1 P19838 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36
▸ CYP3A4 P08684 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ BLM P54132 1/20 0.35
▸ PMP22 Q01453 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ TP53 P04637 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1402309 0.83 HIF1A (0.39) NFKB1NFKB2RELAKMT2AKDM4E
SCHEMBL1402250 0.83 HIF1A (0.39) NFKB1NFKB2RELAKMT2AKDM4E
SCHEMBL4932162 0.83 CNR1 (0.45) CNR1CNR2NFKB1NFKB2RELA
SCHEMBL29180390 0.79 TRPA1 (0.39) NFKB1NFKB2RELAALDH1A1AKT1
SCHEMBL340912 0.77 BID (0.42) KDM4EMAPTALOX15HSD17B10
SCHEMBL258767 0.77 BID (0.42) KDM4EMAPTALOX15HSD17B10
SCHEMBL258691 0.77 BID (0.42) KDM4EMAPTALOX15HSD17B10
SCHEMBL11574798 0.76 AKT1 (0.40) NFKB1NFKB2RELATSHRKMT2A
SCHEMBL8991619 0.76 HIF1A (0.41) CYP3A4TSHRMEN1CYP1A2POLB
SCHEMBL31564929 0.76 BID (0.41) KDM4EMAPTALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250090554-A1 A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION MYND LIFE SCIENCES INC (CA) 2025-03-20 — — US disclosed
Send feedback